Recent Advances in Frontotemporal Dementia.

Frontotemporal dementia (FTD) is a devastating neurodegenerative condition for which there is currently no effective treatment. Although it is much less common than Alzheimer's disease, the impact of FTD is increased by its relatively early onset and high heritability. Clinical heterogeneity and overlap with other neurodegenerative and psychiatric syndromes complicate diagnosis. However, recent advances in our understanding of the molecular basis of FTD provide a foundation for the development of much-needed biomarkers and targeted therapies. This review provides a summary of the recently revised clinical criteria for FTD, highlights diagnostic challenges, briefly summarizes recent molecular discoveries and then focuses on promising developments in biomarkers and clinical trials.

Citation

Maria Carmela Tartaglia, Ian R A Mackenzie. Recent Advances in Frontotemporal Dementia. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2023 Jul;50(4):485-494

Mesh Tags

Substances

PMID: 35634749

search → result